The Epithelial-Mesenchymal Transition and the Estrogen-Signaling in Ovarian Cancer

E-ISSN： 1873-5592|11|4|474-481

ISSN： 1389-4501

Source： Current Drug Targets, Vol.11, Iss.4, 2010-01, pp. : 474-481

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Pathways Contributing to Epithelial-Mesenchymal Transition (EMT) in Epithelial Ovarian Cancer

Current Drug Targets, Vol. 13, Iss. 13, 2012-12 ,pp. : 1649-1653

Bentham Science Publishers

Access to resources Recommend Favorite

Epithelial-Mesenchymal Transition in Ovarian Cancer Progression: A Crucial Role for the Endothelin Axis

Cells Tissues Organs, Vol. 185, Iss. 1-3, 2007-06 ,pp. : 85-94

Karger

Access to resources Recommend Favorite

Epithelial-Mesenchymal Transition: Implications in Cancer Progression and Metastasis

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 11, 2011-11 ,pp. : 1881-1890

Bentham Science Publishers

Access to resources Recommend Favorite

MT1-MMP Activation of TGF-? Signaling Enables Intercellular Activation of an Epithelial-mesenchymal Transition Program in Cancer

Current Cancer Drug Targets, Vol. 16, Iss. 7, 2016-08 ,pp. : 618-630

Bentham Science Publishers

Access to resources Recommend Favorite

Nobiletin inhibited hypoxia-induced epithelial-mesenchymal transition of lung cancer cells by inactivating of Notch-1 signaling and switching on miR-200b

By Gao Xue-Jun Liu Jian-Wei Zhang Qing-Guang Zhang Jing-Jing Xu Hai-Tao Liu Hong-Jian

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 70, Iss. 4, 2015-04 ,pp. : 256-262

Govi-Verlag

Access to resources Recommend Favorite